Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Extending the boundaries of molecular modeling

Article Abstract:

Computers have played a major role in the design of drugs. Computers were utilized in the analysis of quantitative structure-activity relationships (QSARs) in drug discovery research as far back as the 1960's. Computers have been applied to nearly every aspect of the development of drugs since that time. Computers are used for everything from target identification to the formulation of products. The value of computers in the development of pharmaceuticals will only grow.

Comment:

Computers continue to play a major role in drug development research

Author: Sansom, Clare
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1998
United States, General services, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Research and Development in the Physical, Engineering, and Life Sciences, Molecular Biology, Drugs, Article

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


EU enlargement brings biotech opportunities

Article Abstract:

Ten countries from central and eastern Europe (CEE) will join the European Union (EU) giving opportunities to biotech companies both in accession countries and in western Europe. The CEE biotech executives expect that EU membership will bring more venture capitalist (VC) investors to their countries as they are in a position to exploit advantages linked to their location.

Author: Louet, Sabine
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Western Europe

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


EU expansion: enlarged horizons or false dawn?

Article Abstract:

Ten more countries will join the European Union (EU), which will bring more prospects for the biotech sector especially in large countries like Poland, Hungary and the Czech Republic. Many scientists from all the three countries believe that the biggest obstacle in developing their biotech industry is the lack of cooperation between academia and industry.

Author: Sansom, Clare
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Czech Republic, Poland, Hungary, Management dynamics, Drugs, Management, Biotechnology industry, Biotechnology industries, Company business management

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Eastern Europe, Membership, European Union, Economic unions
Similar abstracts:
  • Abstracts: In safe hands? the latest money handling product. Global bingo units. Iaapa
  • Abstracts: Reflections on the theoretical underpinnings of the general-purpose financial reports of Australian government departments
  • Abstracts: Agency costs and the performance implications of international joint venture internalization. An empirical test of heuristics and biases affecting real option valuation
  • Abstracts: Asymmetric corporate exposures to foreign exchange rate changes. Economic exposure and integrated risk management
  • Abstracts: Boeing doesn't eclipse army oversight of FCS: General. V-22 Osprey glitch fixed, critics unconvinced. New procurement guidelines might favor lower-cost systems
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.